This crash course in the development of peptide therapies brings together two articles: one on product research and the other on manufacturing and regulatory concerns.
In “Fighting Alzheimer’s Disease from Within: A Breakthrough Peptide,” freelance journalist Marc Davis highlights current developments in Alzheimer’s disease treatment, focusing specifically on a peptide approach from Canadian company NervGen.
In “Making Peptides Work,” BPI’s senior technical editor adds perspective on developing and manufacturing peptide therapies from the Informa Connect community, with commentary from experts in the industry. Look for remarks from George Perry (editor in chief of the Journal of Alzheimer’s Disease), Rodney Lax (PolyPeptide Group consultant), Michael Karney (CEM Corporation), Tom Barnes (Intellia Therapeutics), and Renata Varga (Teva Pharmaceutical). Market survey results highlight drug delivery and company collaboration, and conversations illuminate manufacturing technologies and quality by design.
Just fill out the form below to read the eBook now.
You May Also Like
